On August 27, Everpure declined 6.57% in regular trading, trading at $98.085/share, with turnover of $123 million. The decline comes despite the company reporting Q2 results that significantly exceeded expectations and receiving a series of analyst upgrades.
Everpure posted fiscal Q2 adjusted EPS of $0.70, beating the consensus estimate of $0.58 by 20.69% and representing a 62.79% year-over-year increase. Revenue came in at $1.186 billion versus the $1.097 billion estimate. The company also guided Q3 revenue of $1.325B-$1.335B, well above the $1.135B consensus, and raised full-year fiscal 2027 revenue guidance to $5.03B-$5.07B versus the Street estimate of $4.50B.
Following the results, Bank of America upgraded Everpure to Buy with a target of $150, while Wedbush raised its target to $130. The stock had already risen over 5% in each of the two prior sessions and gained 5.22% after hours on the earnings release, suggesting the current pullback follows a substantial pre-earnings run-up.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments